Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biogen

128.93
+0.93000.73%
Post-market: 128.930.00000.00%16:20 EDT
Volume:1.11M
Turnover:143.54M
Market Cap:18.90B
PE:12.33
High:131.10
Open:128.47
Low:128.25
Close:128.00
52wk High:207.59
52wk Low:110.04
Shares:146.61M
Float Shares:146.22M
Volume Ratio:0.79
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):10.45
EPS(LYR):11.21
ROE:9.13%
ROA:5.62%
PB:1.07
PE(LYR):11.50

Loading ...

Biogen’s New Study on Felzartamab: A Potential Game-Changer for IgAN Treatment

TIPRANKS
·
Jul 19

Biogen’s New Study on MS Drug Vumerity: Key Insights for Investors

TIPRANKS
·
Jul 18

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and Biogen (BIIB)

TIPRANKS
·
Jul 17

Biogen Executive Makes Significant Stock Sale

TIPRANKS
·
Jul 17

Biogen Inc.'s Head of Global Product Strategy, Izzar Rachid, Reports Disposal of Common Shares

Reuters
·
Jul 17

Biogen Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Jul 16

Wedbush Raises Price Target on Biogen to $129 From $121, Keeps Neutral Rating

MT Newswires Live
·
Jul 15

UBS Remains a Hold on Biogen (BIIB)

TIPRANKS
·
Jul 15

Biogen’s New Study on Omaveloxolone for Young FA Patients: Market Insights

TIPRANKS
·
Jul 15

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ascendis Pharma (ASND) and Biogen (BIIB)

TIPRANKS
·
Jul 14

Biogen Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jul 11

Biogen (BIIB) Gets a Hold from Morgan Stanley

TIPRANKS
·
Jul 10

Stoke Therapeutics Announces Positive Results from Phase 3 Zorevunersen Study for Dravet Syndrome, Highlighting Cognition and Behavior Improvements

Reuters
·
Jul 10

Biogen Insiders Sold US$1.8m Of Shares Suggesting Hesitancy

Simply Wall St.
·
Jul 09

US FDA approves gradual dosing for Lilly Alzheimer's drug

Reuters
·
Jul 09

BRIEF-Eisai Co: Update On Cost-Effectiveness Evaluation Of LEQEMBI By Japan's Health Ministry Council

Reuters
·
Jul 09

Piper Sandler Sticks to Its Hold Rating for Biogen (BIIB)

TIPRANKS
·
Jul 08

BRIEF-Biogen Estimated Charge To Impact EPS By ($0.26) Per Share For Q2

Reuters
·
Jul 08

Biogen Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jul 08

Biogen Faces Q2 Earnings Impact Due to $46 Million Charge

MT Newswires Live
·
Jul 08